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Human Ste20 homologue hPAK1 links GTPases to the JNK 
MAP kinase pathway
Jeffrey L. Brown*, Lisa Stowers*, Margaret Baer†, JoAnn Trejo†, 
Shaun Coughlin† and John Chant*
Background: The Rho-related GTP-binding proteins Cdc42 and Rac1 have
been shown to regulate signaling pathways involved in cytoskeletal
reorganization and stress-responsive JNK (Jun N-terminal kinase) activation.
However, to date, the GTPase targets that mediate these effects have not been
identified. PAK defines a growing family of mammalian kinases that are related to
yeast Ste20 and are activated in vitro through binding to Cdc42 and Rac1
(PAK: p21 Cdc42-/Rac-activated kinase). Clues to PAK function have come
from studies of Ste20, which controls the activity of the yeast mating mitogen-
activated protein (MAP) kinase cascade, in response to a heterotrimeric G
protein and Cdc42.
Results: To initiate studies of mammalian Ste20-related kinases, we identified a
novel human PAK isoform, hPAK1. When expressed in yeast, hPAK1 was able to
replace Ste20 in the pheromone response pathway. Chemical mutagenesis of a
plasmid encoding hPAK1, followed by transformation into yeast, led to the
identification of a potent constitutively active hPAK1 with a substitution of a
highly conserved amino-acid residue (L107F) in the Cdc42-binding domain.
Expression of the hPAK1L107F allele in mammalian cells led to specific activation
of the Jun N-terminal kinase MAP kinase pathway, but not the mechanistically
related extracellular signal-regulated MAP kinase pathway.
Conclusions: These results demonstrate that hPAK1 is a GTPase effector
controlling a downstream MAP kinase pathway in mammalian cells, as Ste20
does in yeast. Thus, PAK and Ste20 kinases play key parts in linking extracellular
signals from membrane components, such as receptor-associated G proteins
and Rho-related GTPases, to nuclear responses, such as transcriptional
activation.
Background
Mitogen activated protein (MAP) kinase pathways are a
broadly conserved mechanism for transducing extracellular
signals that regulate cell growth and development (see [1]
for review). In mammalian cells, the canonical MAP kinase
cascade, composed of Raf, MEK (dual-specificity  ERK
kinase) and ERK (extracellular signal-regulated kinase), is
regulated by the Ras GTPase in response to activation of
growth factor receptors [2]. Ras-dependent activation of
Raf kinase initiates activation of the ERK MAP kinase
cascade, which transmits information to the nucleus and
results in the regulation of genes involved in growth
control [3]. Another related MAP kinase cascade is the Jun
N-terminal kinase (JNK) pathway, composed of MEKK
(MEK kinase-1), JNKK (JNK kinase) and JNK (Jun N-ter-
minal kinase) [4,5]; this pathway is also termed the stress-
activated protein kinase (SAPK) pathway. The JNK MAP
kinase pathway has been shown to be activated by
numerous factors, including protein-synthesis inhibitors,
tumour necrosis factor a (TNFa), and ultraviolet light. In
a striking parallel to the control of the Raf–MEK–ERK
pathway by Ras, the JNK pathway has recently been
shown to be activated by the Rho family GTPases, Cdc42
and Rac1 [6–8]. In previous studies, members of this
family have been shown to be important regulators of
cytoskeletal polarization and actin rearrangements in both
mammalian cells and yeast [9–15]. In fibroblasts, Rho can
induce the formation of actin stress fibers [12,13], whereas
Rac1 can regulate membrane ruffling and lamellipodia for-
mation [14]. Yeast Cdc42 is necessary for polarity during
cell division by budding [9], and mammalian Cdc42 has
recently been shown to be involved in T-cell polarization
[10] and in the formation of filopodia in fibroblasts [11,15].
The downstream targets of Cdc42 or Rac1 that are respon-
sible for JNK1 kinase activation or cytoskeletal organiza-
tion have not been clearly defined. Several candidate
effectors have been described, including the p21 Cdc42-
or Rac-activated serine/threonine kinases (PAKs) [16–19],
the ACK non-receptor tyrosine kinase (ACK: activated
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Cdc42-associated kinase) [20], lipid kinases [21,22],
GTPase-activating proteins [23], and a myosin-related
molecule [24]. Many of the functions of Cdc42 in yeast
seem to be mediated by the serine/threonine kinases
Ste20 and Cla4 [25,26]. Ste20 functions in the activation of
the yeast pheromone response MAP kinase cascade,
consisting of Ste11, Ste7, and Fus3/Kss1, and seems to
coordinate inputs from both a heterotrimeric G protein
and Cdc42 [1,25–28]. Interestingly, Ste20 has recently
been shown to share an important role with the Cla4
kinase in regulating cellular morphogenesis [26].
In this study, we sought to investigate the role of mam-
malian members of the PAK/Ste20 kinase family in medi-
ating the effects of Cdc42 and Rac1. We have cloned a
novel human PAK kinase, hPAK1, and used yeast molecu-
lar genetics to identify a potent constitutive hPAK1 allele.
Through expression of constitutive hPAK1 kinase in
mammalian cells, we have found that hPAK1 specifically
activates the JNK1 MAP kinase pathway in a manner anal-
ogous to the activation of the mating MAP kinase pathway
by Ste20 in yeast.
Results
Identification of a human Ste20 homologue, hPAK1
To initiate studies of mammalian Ste20-related kinases,
we used an approach based on the polymerase chain reac-
tion (PCR) to isolate a PAK isoform, hPAK1, from a
human placental cDNA library [29] (Fig. 1; GenBank
accession number U51120). The amino-acid sequence of
hPAK1 is predicted to be 98 % identical to the originally
described rat PAK [16], differing at eight of 545 amino-
acid residues (boxed in Fig. 1). The hPAK1 protein shares
52 % identity with Ste20 in the amino-terminal Cdc42-
binding regulatory domain and 70 % identity in the
carboxy-terminal kinase domain [25].
hPAK1 can function as Ste20 in budding yeast
The extent of similarity between hPAK1 and Ste20
prompted us to examine the extent of functional conserva-
tion between these kinases. We therefore expressed hPAK1
from the inducible GAL1 promotor in yeast and assayed for
complementation of the ste20-null mating defect [25].
Expression of wild-type hPAK1 efficiently restored mating
of ste20-null cells to near wild-type Ste20+ levels (Fig. 2). As
expected, cells expressing catalytically inactive hPAK1K299A
or vector alone remained unable to mate. Further examina-
tion of the ste20 cells expressing hPAK1 suggested that
other pheromone-induced responses were normal; these
responses included cell-cycle arrest, induction of a tran-
scriptional reporter (FUS1::lacZ; [30]), and the mating
‘‘shmoo’’ morphology (data not shown). As expected, the
ability of PAK to function in yeast was dependent upon the
Ste11 kinase, which is the MAPKKK (MAP kinase kinase
kinase) of the mating response pathway (J.L.B., unpub-
lished observations) and the immediate downstream target
of Ste20 [1]. These results show that the hPAK1 and Ste20
kinases are highly related in function, and that heterologous
expression of hPAK1 is sufficient to coordinate the known
Ste20-dependent mating responses in yeast.
Identification of a constitutively active hPAK1
To study the function of hPAK1 in mammalian cells, we
exploited the finding that hPAK1 complemented ste20 to
identify a constitutively kinase-active hPAK1. A plasmid
encoding hPAK1 was chemically mutagenized and trans-
formed into yeast (see Materials and methods for details).
As induction of the mating response normally results in
cell-cycle arrest before conjugation [1], we sought hPAK1
alleles that slowed growth when expressed. We identified
a single allele of hPAK1 that slowed growth and simulta-
neously induced FUS1::lacZ expression, indicating that
this allele may encode a constitutive kinase. This allele
remained biologically active when tested for its ability to
complement the mating defect of the ste20 strain (Fig. 2).
The activating mutation encoded a change of leucine to
phenylalanine at position 107 (L107F), a highly conserved
residue among the Cdc42-binding domains of Ste20/PAK
family members [16–20].
hPAK1L107F is a potent constitutive kinase
To determine if the hPAK1L107F allele encoded a consti-
tutively active kinase, we compared the relative kinase
activity of hPAK1L107F to that of that of wild-type hPAK1
or hPAK1 induced by GTP-bound forms of Cdc42 or
Rac1 (Fig. 3). When expressed in COS-7 cells, wild-type
hPAK1 activity (lane 2), was induced approximately 40-
fold when coexpressed with Cdc42G12V (lane 5), or 16-
fold when coexpressed with Rac1G12V (lane 6).
Coexpression of RhoAG14V (lane 7) had little effect on
hPAK1 activity, confirming the specificity of activation
by Rac1 and Cdc42, as previously described [6–8].
Remarkably, the kinase activity of hPAK1L107F (lane 3),
was comparable to that of hPAK1 induced by Cdc42G12V
(lane 5) or Rac1G12V (lane 6). The constitutive activity of
hPAK1L107F was affected slightly (less than 2-fold) when
cells were cotransfected with activated (G12V) or domi-
nant-negative (D57Y) forms of Cdc42 (J.L.B. and L.S.,
unpublished observations). These results indicate that
hPAK1L107F is constitutively active and suggest the
L107F substitution in the Cdc42-binding domain
bypasses the need for GTPase activation.
Interestingly, stimulation of the hPAK1 kinase activity, by
the hPAKL107F mutation or by Cdc42G12V, resulted in a
mobility shift corresponding to approximately 5 kDa
which most likely results from autophosphorylation, as
observed previously [16] (Fig. 3). Phosphatase treatment
confirmed that this shift was due to phosphorylation of
hPAK1 (data not shown). The correspondence between
the phosphorylated forms of hPAK1 observed with both
GTPase stimulation and the constitutively active
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hPAK1L107F kinase, provides further evidence that the
hPAK1L107F allele mimics GTPase activation in vivo.
hPAK1 links Cdc42 and Rac1 to the JNK1 MAP kinase
pathway
Recently, Cdc42G12V and Rac1G12V have been shown to reg-
ulate the activity of the JNK pathway [6–8]; we therefore
asked whether hPAK1 also plays a role in the activation of
this pathway. The results in Figure 4 show that expression
of wild-type hPAK1 (lane 3) or kinase-inactive hPAK1K299A
(lane 4) in COS-7 cells had little effect on the kinase activ-
ity of JNK1, as compared to the basal JNK1 activity seen in
transfections with vector alone (lane 2). In contrast, expres-
sion of hPAK1L107F strongly induced the activity of JNK1
towards c-Jun (lane 5). The level of JNK1 activity induced
by hPAK1L107F was comparable, although not identical, to
Figure 1
1                     GGAGAGCCGAGAGGAGCTGAGCGAGCGCGGAAGTAGCTGCTGCTGGTGGTGACA
55 ATG TCA AAT AAC GGC CTA GAC ATT CAA GAC AAA CCC CCA GCC CCT CCG ATG AGA AAT ACC AGC ACT 
M   S   N   N   G   L   D   I Q   D   K   P   P   A   P   P   M   R   N   T   S   T 22
121 ATG ATT GGA GCC GGC AGC AAA GAT GCT GGA ACC CTA AAC CAT GGT TCT AAA CCT CTG CCT CCA AAC 
M   I   G   A   G   S   K   D   A G   T   L   N   H   G   S   K   P   L   P   P   N 44
187 CCA GAG GAG AAG AAA AAG AAG GAC CGA TTT TAC CGA TCC ATT TTA CCT GGA GAT AAA ACA AAT AAA 
P   E   E   K   K   K   K   D   R   F   Y   R   S   I   L   P G   D   K   T   N   K 66
253 AAG AAA GAG AAA GAG CGG CCA GAG ATT TCT CTC CCT TCA GAT TTT GAA CAC ACA ATT CAT GTC GGT 
K   K   E   K   E   R   P   E   I   S   L   P   S   D   F   E   H   T   I   H   V   G 88
319 TTT GAT GCT GTC ACA GGG GAG TTT ACC GGA ATG CCA GAG CAG TGG GCC CGC TTG CTT CAG ACA TCA 
F   D   A   V   T   G   E   F   T   G   M   P   E   Q   W   A   R   L   L* Q   T   S 110
385 AAT ATC ACT AAG TCG GAG CAG AAG AAA AAC CCG CAG GCT GTT CTG GAT GTG TTG GAG TTT TAC AAC 
N   I   T   K   S   E   Q   K   K   N   P   Q   A   V   L   D   V   L   E   F   Y   N 132
451 TCG AAG AAG ACA TCC AAC AGC CAG AAA TAC ATG AGC TTT ACA GAT AAG TCA GCT GAG GAT TAC AAT 
S   K   K   T   S   N   S   Q   K   Y   M   S   F   T   D   K   S   A   E   D   Y N 154
517 TCT TCT AAT GCC TTG AAT GTG AAG GCT GTG TCT GAG ACT CCT GCA GTG CCA CCA GTT TCA GAA GAT 
S   S   N   A L   N   V   K   A V   S   E   T   P   A   V   P   P   V   S   E   D 176
583 GAG GAT GAT GAT GAT GAT GAT GCT ACC CCA CCA CCA GTG ATT GCT CCA CGC CCA GAG CAC ACA AAA 
E   D   D   D   D   D   D A   T   P   P   P   V   I   A   P   R   P   E   H   T   K 198
649 TCT GTA TAC ACA CGG TCT GTG ATT GAA CCA CTT CCT GTC ACT CCA ACT CGG GAC GTG GCT ACA TCT 
S   V   Y   T   R   S   V   I   E   P   L   P   V   T   P   T   R   D   V   A   T   S 220
715 CCC ATT TCA CCT ACT GAA AAT AAC ACC ACT CCA CCA GAT GCT TTG ACC CTT AAT ACT GAG AAG CAG 
P   I   S   P   T   E   N   N   T   T   P   P   D   A   L   T   L N   T   E   K   Q 242
781 AAG AAG AAG CCT AAA ATG TCT GAT GAG GAG ATC TTG GAG AAA TTA CGA AGC ATA GTG AGT GTG GGC 
K   K   K   P   K   M   S   D   E   E   I   L   E   K   L   R   S   I   V   S   V G 264
847 GAT CCT AAG AAG AAA TAT ACA CGG TTT GAG AAG ATT GGA CAA GGT GCT TCA GGC ACC GTG TAC ACA 
D   P   K   K   K   Y   T   R   F   E   K   I   G   Q   G   A   S   G   T   V   Y   T 286
913 GCA ATG GAT GTG GCC ACA GGA CAG GAG GTG GCC ATT AAG CAG ATG AAT CTT CAG CAG CAG CCC AAG 
A   M   D   V   A   T   G   Q   E   V   A   I   K   Q   M   N   L   Q   Q   Q   P   K 308
979 AAA GAG CTG ATT ATT AAT GAG ATC CTG GTC ATG AGG GAA AAC AAG AAC CCA AAC ATT GTG AAT TAC 
K   E   L   I   I   N   E   I   L   V   M   R   E   N   K   N   P   N   I   V   N   Y 330
1045 TTG GAC AGT TAC CTC GTG GGA GAT GAG CTG TGG GTT GTT ATG GAA TAC TTG GCT GGA GGC TCC TTG 
L   D   S   Y   L   V   G   D   E   L   W   V   V   M   E   Y   L   A   G   G   S   L 352
1111 ACA GAT GTG GTG ACA GAA ACT TGC ATG GAT GAA GGC CAA ATT GCA GCT GTG TGC CGT GAG TGT CTG 
T   D   V   V   T   E   T   C   M   D   E   G   Q   I   A   A   V   C   R   E   C L 374
1177 CAG GCT CTG GAG TCT TTG CAT TCG AAC CAG GTC ATT CAC AGA GAC ATC AAG AGT GAC AAT ATT CTG 
Q   A   L   E   S L   H   S   N   Q   V   I   H   R   D   I   K   S   D   N   I   L 396
1243 TTG GGA ATG GAT GGC TCT GTC AAG CTA ACT GAC TTT GGA TTC TGT GCA CAG ATA ACC CCA GAG CAG 
L   G   M   D   G   S   V   K   L   T   D   F   G   F   C   A   Q   I   T   P   E   Q 418
1309 AGC AAA CGG AGC ACC ATG GTA GGA ACC CCA TAC TGG ATG GCA CCA GAG GTT GTG ACA CGA AAG GCC 
S   K   R   S   T   M   V   G   T   P   Y   W   M   A   P   E   V   V   T   R   K   A 440
1375 TAT GGG CCC AAG GTT GAC ATC TGG TCC CTG GGC ATC ATG GCC ATC GAA ATG ATT GAA GGG GAG CCT 
Y   G   P   K   V   D   I   W   S   L   G   I   M   A   I   E   M   I   E   G   E   P 462
1441 CCA TAC CTC AAT GAA AAC CCT CTG AGA GCC TTG TAC CTC ATT GCC ACC AAT GGG ACC CCA GAA CTT 
P   Y   L   N   E   N   P   L   R   A   L   Y   L   I   A   T   N   G   T   P   E   L 484
1507 CAG AAC CCA GAG AAG CTG TCA GCT ATC TTC CGG GAC TTT CTG AAC CGC TGT CTC GAG ATG GAT GTG 
Q   N   P   E   K   L   S   A   I   F   R   D   F   L   N   R   C   L   E   M   D   V 506
1573 GAG AAG AGA GGT TCA GCT AAA GAG CTG CTA CAG CAT CAA TTC CTG AAG ATT GCC AAG CCC CTC TCC 
E   K   R   G   S   A   K   E   L   L   Q   H   Q   F   L   K   I   A   K   P   L   S 528
1639 AGC CTC ACT CCA CTG ATT GCT GCA GCT AAG GAG GCA ACA AAG AAC AAT CAC TAA AACCACACTCACCCC
S   L   T   P   L   I   A   A   A   K   E   A   T   K   N   N   H   Stop 545
1708 AGCCTCATTGTGCCAAGCCTTCTGTGAGATAAA
Predicted sequence of hPAK1. Nucleotide and predicted amino-acid
sequence of human hPAK1. The predicted Cdc42-binding domain
(amino-acid residues 75–132) and the kinase domain (amino-acid
residues 270–516) are underlined. The amino-acid residues that are
different from the previously identified rat brain PAK [16] are boxed.
The position of the leucine to phenylalanine substitution in hPAKL107F,
which renders the kinase constitutively active, is indicated by the
asterisk.
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the level of JNK1 activity produced by expression of
Cdc42G12V or Rac1G12V (lanes 6 and 7), or by ultraviolet
treatment (lane 9). The specific induction of JNK1 kinase
activity by the hPAK1L107F allele, along with activation of
hPAK1 by Cdc42G12V or Rac1G12V (Fig. 3), argues that
hPAK1 acts directly in the JNK1 MAP kinase pathway to
mediate communication between Cdc42/Rac1 GTPases
and the MEKK kinase (a MAPKKK). This possibility is
further supported by our observation that hPAK1 function
in yeast is directly dependent on the analogous
MAPKKK, Ste11.
hPAK1 does not activate the ERK MAP kinase pathway
To address the possibility that activation of the JNK1
pathway by hPAK1L107F reflected a non-specific activation
of MAP kinase pathways, we tested the effects of
hPAK1L107F on the Raf–MEK–ERK pathway (Fig. 5). It
has previously been shown that expression of activated
Cdc42 or Rac1, at levels sufficient to activate the JNK1
pathway, did not induce the Raf–MEK–ERK cascade
[6–8]. We confirmed that constitutively active MEK
(MEK-EE; [6]) and Raf (Raf BXB; [31]) could potently
activate ERK (lanes 6 and 7). In marked contrast, expres-
sion of wild-type, catalytically inactive, or constitutively
active hPAK1 failed to induce ERK activity (lanes 3, 4, and
5), which remained at basal levels in these cells (compare
lanes 3, 4 and 5 to lane 1). Thus, the activation of the JNK1
MAP kinase pathway by the hPAK1L107F allele does not
reflect general activation of MAP kinase-type pathways. 
Discussion
In this report, we have described our investigations of a
human Ste20-related kinase, hPAK1. Remarkably, we
have found that hPAK1 can replace Ste20 in the mating
response pathway of yeast, suggesting that the functions
of PAK and Ste20 may be more closely related than previ-
ously described. On the basis of PAK function in yeast, we
were able to identify a biologically active, constitutive
allele of hPAK1, which bypasses the need for activation by
Figure 3
hPAK1L107F acts as a potent constitutive kinase. (a) The kinase activity
of hemagglutinin (HA)-tagged hPAK1 (HA–hPAK1) was determined by
immunoprecipitation from subconfluent COS-7 cells transfected with
constructs expressing the indicated proteins. Kinase activity was
assayed using myelin basic protein (MBP) as a substrate.
Phosphorylated species of MBP and hPAK1 are indicated by the
arrows. Fold-stimulation above the basal hPAK1 activity in cells
transfected with vector and HA–hPAK1 construct is indicated (see
Materials and methods). (b) Immunoblot of immunoprecipitated HA-
–hPAK1 showing the relative protein levels in each kinase assay.
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Figure 2
hPAK1 complements ste20 in the mating
signal transduction pathway. Expression of
wild-type hPAK1 and hPAK1L107F restores
mating to a ste20-null strain. Three
independent ste20D::URA3 colonies
expressing the indicated constructs, along
with a control Ste20+ strain were replica-
plated onto a mating tester lawn of opposite
mating type on (a) galactose or (b) glucose
media. Permissive mating was performed at
30 °C for 10 h on galactose to induce hPAK1
expression, or for 3 h on glucose (no hPAK1
expression), before scoring diploid formation
by His+ prototrophy, as shown here after 2
days of incubation at 30 °C.
STE20 + vector
ste20∆ + hPAK1L107F
ste20∆ + hPAK1WT
ste20∆ + hPAK1K299A
ste20∆ + vector
Galactose Glucose
(a) (b)
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Rho-related GTPases. Finally, we used this constitutive
allele to show that PAK is likely to be the GTPase effector
responsible for activating the JNK MAP kinase pathway.
An expanding family of Ste20-related kinases
Recently, a large number of Ste20-related kinases have
been described [16–19,26,32,33]. To date, these kinases can
be broadly divided into two classes which differ in several
respects. The first class includes Cla4, rat PAK (p65),
PAK65, human hPAK1 (described here), and several others
[16–19,26]. The second class includes germinal center (GC)
kinase and upstream kinase (UK) [32,33]. Members of the
first group are considerably more closely related by
sequence to Ste20. They contain a Cdc42-/Rac1-binding
domain, and they have an overall structure of regulatory
domains amino-terminal to the kinase domain. In contrast,
members of the second group are more distantly related to
Ste20 by sequence. They have no identifiable GTPase
binding domain, and their regulatory domains are carboxy-
terminal to the kinase domain. Interestingly, mammalian
members of both classes, namely hPAK1 kinase and GC
kinase, have been shown to activate MAP kinase cascades
(Fig. 4; [32,34,35]). The important difference between
these two classes of kinases may lie in the inputs that
control kinase activity: PAK-related kinases are regulated
by Rho-related GTPases [16], whereas GC/UK kinases may
be regulated by distinct signaling components.
Further conservation of the Cdc42/Ste20 pathway?
The yeast pheromone response pathway is a particularly
well characterized MAP kinase cascade (Fig. 6; [1]). Ste20
activates this pathway in response to signals from both
Cdc42 and the heterotrimeric G protein associated with
transmembrane pheromone receptors. Although closely
related mammalian homologs of Cdc42, Ste20, and MAP
kinase cascade components are known, several important
proteins in this pathway have no known mammalian coun-
terparts — in particular the SH3-containing protein Bem1
[36] and the proposed MAP kinase scaffold Ste5 [37,38].
The observation that hPAK1 is capable of coordinating
Figure 4
Activation of the JNK1 kinase pathway by constitutively active
hPAK1L107F. (a) The activity of HA-tagged JNK1 (HA–JNK1)
immunoprecipitated from COS-7 cells expressing the indicated
constructs. The kinase activity of HA–JNK1 was determined using
GST-tagged c-Jun as substrate. As an additional control, HA–JNK1
was activated by UV treatment for 5 min (lane 9). Fold stimulation
relative to that of HA–JNK1 in cells transfected with vector and
HA–JNK1 construct is indicated (see Materials and methods). (b)
Immunoblot of HA–hPAK1 showing relative expression levels. (c)
Immunoblot of immunoprecipitated HA–JNK1 showing the relative
protein levels in each kinase assay.
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Figure 5
hPAK1L107F does not induce ERK activity. (a) The activity of ERK1 and
ERK2 proteins immunoprecipitated from COS-7 cells expressing the
indicated constructs. ERK was immunoprecipitated with anti-ERK
antibodies and its kinase activity was determined by analysis of MBP
phosphorylation. Fold-stimulation above the activity of HA–ERK2 in
cells transfected with vector and HA–ERK2 construct is indicated (see
Materials and methods). (b) Immunoblot of HA–hPAK1 in lysates to
show relative expression levels. (c) Immunoblot of ERK2 (upper band)
in immunoprecipitates. The upper band (ERK2), migrates more slowly
than endogenous ERK1 because of the presence of the HA tag.
ERK2:
MBP
hPAK1
ERK2
Fold
activation:
Lane:
1	 1	 1	 1	 1	 8	 5
1		 2	 3	 4	 5	 6	 7
(a)
(b)
(c)
–		 +	 +	 +	 +	 +	 +
Ve
ct
or

Ve
ct
or

hP
A
K
1K
29
9A

hP
A
K
1
hP
A
K
1L
10
7F

M
E
K
E
E

R
af
B
X
B


diverse cellular functions in yeast — including cell-cycle
arrest, transcriptional activation, and the induction of mor-
phological changes — raises the possibility that PAK inter-
acts directly with these components, and implies that
mammalian homologs of Ste5 and Bem1 may exist.
The observation that hPAK1 can complement ste20 is
notable in a second regard. Recently, the rat PAK1 protein
expressed in ste20 mutants was reported to be unable to
support Ste20 function [39]. The difference between these
results and ours is particularly interesting in that the hPAK1
reported here differs from rat PAK1 at only eight of 545
amino-acid residues (Fig. 1). It is possible that one or more
of these differences define important protein-interaction
interfaces.
Identifying useful alleles of mammalian signaling
components by yeast genetics
Using the molecular genetics available in yeast, we were
able to isolate a potent constitutively kinase-active hPAK1.
The constitutive activity of this kinase results from a single
point mutation located in the Cdc42-binding region, sug-
gesting that this mutation mimics activation by GTP-bound
forms of Cdc42 or Rac1. Interestingly, sequence compari-
son reveals that the leucine residue at position 107 is a con-
served residue in the Cdc42-binding domain of
Ste20/PAK-related serine/threonine kinases and the ACK
non-receptor tyrosine kinase. Construction of constitutive
alleles of these proteins should also prove useful in the
analysis of their cellular functions.
Possible mechanisms of PAK activation
Biochemical characterization of the hPAK1L107F kinase sug-
gests that L107F bypasses the need for GTPase-dependent
activation of kinase activity. However, we expect that there
will be additional mechanisms by which hPAK1 activity can
be regulated. This possibility is supported by the finding
that hPAK1L107F produces a more potent kinase activity
than wild-type hPAK1 cotransfected with Cdc42G12V (Fig.
3), yet transfection of Cdc42G12V produces more potent acti-
vation of the JNK1 pathway (Fig. 4). We consider it likely
that the subcellular localization of PAK kinase activity will
also prove important in the regulation of its function.
Perhaps Rho-related GTPases regulate PAK function by
inducing conformational activation through binding and by
docking PAK at the plasma membrane in the vicinity of its
substrates.
The importance of GTPases in localizing effector kinases
is demonstrated by the Ras–Raf paradigm: it is proposed
that Ras functions by localizing Raf to the plasma mem-
brane, where Raf is activated by Ras-independent mecha-
nisms [3]. Cdc42–PAK regulation is not entirely analogous
to Ras–Raf, because binding of Cdc42 to PAK is sufficient
to induce kinase activity [16]. A distinct combinatorial
mechanism of GTPase-induced conformational activation
and localization may be operating in the regulation of
Ste20-/PAK-related kinases.
PAK controls the JNK MAP kinase pathway in response to
Cdc42 and Rac1
Previously it has been shown that recombinant forms of
Cdc42 and Rac1 dramatically activate PAK activity in
vitro, and that overexpression of these GTPases leads to
activation of the JNK MAP kinase pathway. The results
presented in this report, together with the work of others
[34,35], clearly demonstrate that PAK kinases are GTPase
effectors that mediate activation of the JNK kinase
pathway.
Where does PAK kinase act in MAP kinase pathways?
Evidence from yeast and mammalian cells suggests that
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Figure 6
Ste20 and PAK link Cdc42 to MAP kinase
cascades in both yeast and mammals. Model
showing the parallels between Ste20/PAK
signalling pathways in budding yeast and
mammalian cells. In yeast, Cdc42 GTPase
activates the serine/threonine kinases Cla4
and Ste20, resulting in cytoskeletal
reorganization and Ste20-dependent
activation of the pheromone response
pathway. We speculate that two analogous
pathways may also exist in mammalian cells.
Cdc42 and Rac1 have both been shown to
regulate cytoskeletal reorganization in
mammalian cells; however, the roles of hPAK1
or the JNK pathway in mediating these effects
are presently unclear.
PAK
MEKK
JNKK
JNK
α β
γ
α β
γ
Ste20 Cla4
Ste11
Ste7
Fus3/Kss1
Cdc42
Rac
?
? ? ?
Cell-cycle arrest,
transcription
TranscriptionBudding,
cytokinesis
Cytoskeletal
organization
Mammalian cellsBudding yeast(a) (b)
Cdc42
© 1996 Current Biology
PAK directly mediates the communication between the
Cdc42/Rac1 GTPases and MEKK in the JNK pathway.
Ste20 and PAK kinases have been shown to bind to Cdc42
and Rac1 proteins in vitro, and the complementation of
ste20 cells by hPAK1 is dependent upon Ste11, the MEKK
homolog in the pheromone response pathway. Thus, we
conclude that PAK is likely to act as a GTPase-responsive
MAPKKKK in the JNK pathway (Fig. 6).
Conclusions
In this report, we have shown that the human PAK
homolog, hPAK1, acts as a GTPase effector which links
the Rho-related GTPases to the JNK MAP kinase
pathway. In addition to JNK kinase activation, which
leads to c-Jun mediated transcriptional activation, these
GTPases have been shown to coordinate mitogenesis and
cytoskeletal rearrangements [8–15]. An important issue
remaining to be addressed is the nature of the branching
in these signaling pathways that allows these GTPases to
control such diverse effects. It is worth noting that the
cytoskeletal changes mediated by injection of Rac1 or
Cdc42 proteins are probably too rapid to result from tran-
scriptional induction by the JNK pathway and c-Jun.
However several additional possibilities merit considera-
tion. Firstly, the components of the JNK pathway may
play a direct role in cytoskeletal responses in addition to
nuclear responses; secondly, PAKs may have additional
targets involved in cytoskeletal rearrangement; and
thirdly, the cytoskeletal changes elicited by Rho-related
GTPases may be produced by effectors unrelated to
PAK. Understanding the mechanisms by which cells
coordinate these responses should provide valuable infor-
mation on how these signaling pathways may be adapted
to the regulation of multiple cellular functions.
Materials and methods
Isolation of human hPAK1
Degenerate oligonucleotide primers (TGGT(CG)AT(AT)A(TC)GGA-
(AG)TACATG and TA(TA)GG(CA)GG(TC)TC(AC)CC(TC)TC(TG)AT-
CAT), based upon conserved regions within the kinase domains of
Ste20 and Scprokin (GenBank accession number X69322) were used
to PCR amplify first strand cDNA derived from the Dami megakaryocyte-
related cell line. A PCR product was identified and used to probe a
human placental cDNA library [29]. A 2.0 kb cDNA fragment was initially
identified, and was used to reprobe the placental cDNA library to isolate
a second 3.2 kb cDNA. The full-length hPAK1 was assembled by ligation
of a BamHI–StuI fragment of the 3.2 kb clone into the BamHI–StuI sites
of the 2.0 kb fragment in the vector Bluescript KS+ (Stratagene). The
insert was sequenced on both strands and is predicted to encode a
protein of 545 amino acids, with a molecular mass of 61 kDa. A plasmid
encoding a functional hPAK1 with an amino-terminal HA tag was con-
structed, from which a HA-tagged catalytically inactive hPAK1 (K299A)
was made, using Kunkel mutagenesis [40] and oligonucleotide primers
(HA, CTGGTGGTGACAGGTACCAT-GGACGTGCCGGACTACGC-
TTCCTCAAATAACGCCTA; and K299A, GAGGTGGCCATTGCGCA-
GATGAATCTT). HA-tagged versions of hPAK1 were used in all
experiments described.
Accession number
The GenBank accession number for the hPAK1 sequence is U51120.
hPAK1 complementation of ste20 
HA-tagged hPAK1, hPAK1L107F (see below) and hPAK1K299A were
expressed from 2.2 kb KpnI fragments subcloned into a pRS315-
based vector [41] containing the yeast GAL1 promotor and the LEU2
selectable marker (plasmids pGAL1-hPAK1, pGAL1-hPAK1L107F and
pGAL1-hPAK1K299A, respectively). Each plasmid, and the vector alone,
were transformed into strain MATa ste20D::URA3 his3 ura3 leu2
ade2 lys2, and three independent transformants of each construct
were patched on synthetic complete (SC) plates lacking leucine [42].
Patches were then replica-plated onto a mating tester lawn (JC27:
MATa his4 trp1 ura3) on either YPD plates or YPGal plates to induce
hPAK1 expression. Mating reactions were incubated at 30 °C for 10 h
on galactose, or 3 h on glucose, and replica-plated to SC glucose
plates lacking histidine to assay for diploid formation (His+).
Isolation of constitutively active hPAK1 kinase
The pGAL1-hPAK1 plasmid (described above) was chemically mutage-
nized with hydroxylamine [42], amplified in E. coli, and transformed into
yeast strain JC66 (MATa leu2 ura3 trp1). Approximately 40 000 trans-
formants were screened for slowed growth in SC galactose plates
lacking leucine [43]. Six such plasmids were isolated, one of which
(hPAK1.36) led to constitutive activation of pheromone induced tran-
scription assayed with a FUS1::lacZ reporter [41]. The sequence of
this clone revealed the presence of three point mutations, and separa-
tion of these mutations indicated that the constitutive activity was due
entirely to an L107F mutation. All further experiments were performed
with the single L107F mutant denoted hPAK1L107F.
Mammalian cell culture and transfections
For all transient transfections COS-7 cells were grown in RPMI-1640
medium (Gibco BRL) supplemented with 10 % fetal bovine serum
(Hyclone), 60 mg ml–1 glutamine, 10 U ml–1 penicillin and 10 U ml–1
streptomycin. Subconfluent cells were transfected in 100 mm dishes
using the Lipofectamine reagent (Gibco BRL) with DNA at a constant
8 mg per plate (supplemented with pCDNA3 vector when necessary).
Cells were serum starved for 16 h prior to kinase assays which were per-
formed 48 h following transfection. To investigate the possibility that
JNK1 activation observed in this report was produced by an autocrine
loop rather than an intracellular signaling pathway, culture supernatants
from cells transfected with plasmids expressing Cdc42G12V or PAKL107F
were added to cells transfected with HA–JNK alone. Culture super-
natants had little or no effect upon JNK1 activity (J.L.B., unpublished
observations).
Immunoprecipitations and kinase assays
Cells were washed twice with PBS containing 5 mM EDTA, and lysed
at 4 °C in lysis buffer (150 mM NaCl, 50 mM Tris (pH 8.0), 1 mM
EDTA, 0.1 % Triton X-100, 1 mg ml–1 bovine serum albumin, 1 mM
PMSF, 10 mg ml–1 aprotinin and 10 mg ml–1 leupeptin). Typically,
immunoprecipitations were performed with 6 mg monoclonal 12CA5
antibody (anti-HA) for HA–hPAK1 or HA–JNK1 (Boehringer
Mannheim), or with a similar amount of anti-ERK polyclonal antiserum
(Santa Cruz Biotechnology Inc.). Immune complexes, formed by incu-
bation at 4 °C for 1 h, were recovered by adding protein A beads
(Pierce) and centrifuging. Beads were washed twice in lysis buffer
and twice in kinase buffer (100 mM NaCl, 50 mM Tris (pH 7.5),
10 mM MgCl2 and 1 mM MnCl2). Kinase assays were performed in
50 ml reactions with 10 mM ATP, 1 mCi g-[32P]ATP and either 3 mg
MBP (Sigma) or GST-tagged c-Jun (amino acids 1–79; [4]). After
20 min at 30 °C, reactions were terminated by addition of 10 ml 5 ×
Laemmli sample buffer [44], heated to 95 °C and separated by
SDS–PAGE [44]. Autoradiographs were typically exposed for
30–40 min with an intensifier screen.
Western blots of protein extracts or immunoprecipitated proteins were
performed using standard methods [44]. Measurement of MBP or c-
Jun phosphorylation was performed by excising bands from the SDS–
PAGE gel shown in each figure, and determining radioactivity (cpm)
using a Beckman LS6000 IC scintilation counter. Numbers reported
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are relative values compared to transfections with vector plus
HA–hPAK1 construct (Fig. 3), vector plus JNK1 construct (Fig. 4), and
vector plus ERK2 construct (Fig. 5).
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